期刊文献+

二氢杨梅素胃内漂浮片处方研究 被引量:6

Formula Study on Gastric-retention Tablets of Dihydromyricetin
原文传递
导出
摘要 目的为了延长二氢杨梅素在胃内停留的时间,延缓药物的释放,将其制备成胃内漂浮片。方法采用粉末直接压片法制片,运用单因素的平行实验和L9(34)正交设计,以起漂时间、漂浮持续时间及释放度为指标选择最佳处方。结果最佳处方:片剂重量为300 mg,其他各成分的含量分别为:HPMC K4M 75 mg,PVP K30 40 mg,NaHCO3 40 mg,主药80 mg,乳糖65 mg,该制剂在37℃的人工胃液中立即起漂,12 h释放>90%,持漂时间>10 h。结论制备的胃漂浮片具有优良的漂浮能力和释药行为,可增加二氢杨梅素在胃部的滞留时间,提高药物的稳定性,增强保肝作用。 OBJECTIVE To prepare and characterize gastric-retention sustained-release tablets of dihydromyricetin which is expected to prolong its floating time in stomach. METHODS Direct compression was used to prepare tablets, single factor experiment and orthogonal experimental design were used to optimize of the formulation based on the index such as the time to start floating, lasting time and the drug release rate. RESULTS The optimum formulation of 300 mg included: HPMC K4M 75 mg, PVP K30 40 mg, NaHCO3 40 mg, dihydromyricetin 80 mg, lactose 65 mg. In the artificial gastric juice of 37 ~C, the results showed that the products could immediately float, the drug released more than 90% within 12 h and the durative floating time was more than 10 h. CONCLUSION These prepared gastric-retention tablets show a good continual floating property and sustained-release, it could increase residence time and improve the stable of drug, also improve the efficacy for liver protection.
出处 《中国现代应用药学》 CAS CSCD 2014年第2期182-186,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 二氢杨梅素 胃内漂浮片 制备工艺 dihydromyricetin gastric-retention tablets preparation technology
  • 相关文献

参考文献6

二级参考文献60

共引文献91

同被引文献65

  • 1柯瑜,郭慧玲.HBS型胃内滞留漂浮型制剂的研究概况[J].江西中医学院学报,2006,18(2):71-73. 被引量:5
  • 2欧阳玉祝,麻成金,李志平,杨朝霞,刘炫程.二氢杨梅素-β-环糊精包络物抗氧化稳定性及其动力学研究[J].食品与发酵工业,2006,32(10):37-40. 被引量:4
  • 3黄继红,姚茂君.二氢杨梅素微胶囊化壁材的优化研究[J].现代食品科技,2007,23(6):35-37. 被引量:2
  • 4何桂霞,裴刚,李斌,欧阳文.二氢杨梅素的稳定性研究[J].中国新药杂志,2007,16(22):1888-1890. 被引量:31
  • 5Ruan L, Yu B, Fu G, et al. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes [J]. JPharm Biomed, 2005, 38(3): 457-464.
  • 6Zhou J, Zeng P, Tu H H, et al. Development and application of high-performance liquid chromatography for the study of ampelopsin pharmacokinetics in rat plasma using cloud-point extraction [J]. J Sep Sci, 2011, 34(2): 160-168.
  • 7Huang H, Hu M, Zhao R, et al. Dihydromyricetin suppresses the proliferation of hepatocellular carcinoma cells by inducing G2/M arrest through the chkl/chk2/cdc25c pathway [J]. Oncol Rep, 2013, 30(5): 2467-2475.
  • 8Shen Y, Lindemeyer A K, Gonzalez C, et al. Dihydromyricetin as a novel anti-alcohol intoxication medication [J]. J Neurosci: Official J Soc Neurosci, 2012, 32(1): 390-401.
  • 9Immordino M L, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential [J]. Int J Nanomed, 2006, 1(3): 297-315.
  • 10Lawrence M J, Rees G D. Microemulsion-based media as novel drug delivery systems [J]. Adv Drug Deliv Rev, 2000, 45(1): 89-121.

引证文献6

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部